Not Tagged
mainz biomed
[]
we look forward to welcoming you at esmo world congress on gastrointestinal cancer 2023 at booths 105 a + b. 
Mainz BioMed (NASDAQ: $MYNZ) develops market-ready molecular genetic diagnostic solutions for life-threatening conditions, such as #colorectal cancer.